Morepen Laboratories Limited has informed the Exchange about execution of loan agreement and other related document with KEB Hana Bank
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Morepen Laboratories' Finance Committee approved an unsecured working capital term loan of Rs. 30 Crore from KEB Hana Bank on March 10, 2026. The loan carries an interest rate of repo rate plus 2.05% per annum (current effective rate of 7.30%), with a 3-year tenure, a 6-month moratorium, and repayment in 5 half-yearly equal installments. The facility is backed by a personal guarantee from promoter and Chairman & MD Mr. Sushil Suri. The company has no existing outstanding loan from KEB Hana Bank, while its total outstanding debt (excluding this loan and vehicle loans) stands at Rs. 164.62 Crore. The loan is intended for general working capital needs and is not a related-party transaction.
This new Rs. 30 Crore unsecured facility strengthens the company's working capital position and adds to its existing debt of Rs. 164.62 Crore, increasing total borrowings to around Rs. 194.62 Crore. The competitive pricing and promoter guarantee suggest the promoter is backing the company's creditworthiness, which is mildly positive for lenders and signals management confidence.